Reproducibility and validity of microbiomial markers in colorectal cancer

结直肠癌微生物标志物的重现性和有效性

• 批准号: 8788702
• 负责人: Martha J. Shrubsole
• 金额: $ 5.64万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-01-01 至 2016-04-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8788702
• 关键词: Address; Adopted; Adult; Affect; Anoxia; Apoptosis; Bacteria; Bioinformatics; Biological Markers; Cancer Etiology; Cataloging; Catalogs; Cell Proliferation; Cessation of life; Chemoprevention; Collection; Colorectal; Colorectal Adenoma; Colorectal Cancer; Colorectal Neoplasms; Communities; Development; Diet; Disease; Endoscopy; Epidemiologic Studies; Epidemiology; Epithelium; Evaluation; Feces; Foundations; Future; Growth; Harvest; Health; Human; Human Microbiome; Immunity; Immunohistochemistry; Incidence; Individual; Inflammation; Intervention Trial; Intestines; Investigation; Malignant Neoplasms; Measures; Microbe; Mucous Membrane; Organ; Oxygen; PTGS2 gene; Parents; Participant; Pathway interactions; Patients; Persons; Pilot Projects; Prevalence; Prevention strategy; Prevention trial; Public Health; RNA, Ribosomal, 16S; Recommendation; Recording of previous events; Reproducibility; Research; Ribosomal RNA; Risk Factors; Role; Sample Size; Sampling; Solid; Source; Spottings; Swab; Time; Tissues; Validity and Reliability; Weight; cancer risk; carcinogenesis; clinically significant; colon carcinogenesis; colorectal cancer prevention; design; high risk; microbial; microbiome; modifiable risk; mortality; next generation sequencing; novel; nutrient metabolism; personalized screening; public health relevance; rectal; tool; virtual

DESCRIPTION (provided by applicant): Despite a reduction in both incidence and mortality of colorectal cancer, partially due to rapidly increased use of endoscopy, colorectal cancer (CRC) still remains the 4th most common incident cancer and the 2nd most common cause of cancer death in the US. Thus, it is critical to develop new prevention strategies. The human colorectum is host to billions of bacteria which comprise the microbiota. The microbiota is essential in several functions of colorectal health including immunity, nutrient metabolism, growth, and energy harvesting. However, until recently, evaluation of the role of microbiota in health has been limited because the majority of bacteria are uncultivable. Cultivation-independent next-generation sequencing of 16S ribosomal RNA has permitted the evaluation of the role of microbiota in health. However, previous epidemiological studies of the colorectal microbiome are few and with small sample sizes. Furthermore, recent studies found oxygen gradients in the intestine are the steepest in the body, which reduce from mucosa to near anoxia at the middle of the lumen. Thus, microbes in luminal communities are more likely to be anaerobic compared to mucosal bacteria. Thus, before conducting large-scale epidemiological studies, it is necessary to address two key methodological or practical questions. First, what source(s) of sample(s) is/are most appropriate for analysis of the human colorectal microbiome, and, second, whether a spot sample is adequately reliable for representing the colorectal microbiome in relation to colorectal carcinogenesis. This proposed study will address these two key issues by using banked fecal samples and paired rectal swabs from 2 time points among 100 participants with a history of colorectal adenoma (4 samples from each person). In the parent study, colorectal carcinogenesis biomarkers (apoptosis, inflammation, proliferation and Wnt pathway) are measured in normal rectal tissue at the same 2 time points as the fecal and rectal swab samples. In this proposed pilot study, the samples will be analyzed using next-generation sequencing of 16S rRNA. We will compare 1) swabs to stool and 2) the combination of swab and stool to the single sample type in association with immunohistochemistry carcinogenesis biomarkers. We will also examine whether the microbial biomarkers in rectal swabs and stool samples remain stable over time; and further 2) to compare microbial biomarkers in stool and rectal swabs collected at one time point (spot collection) with microbial biomarkers from two time points (3 months apart) in their correlation with immunohistochemistry carcinogenesis biomarkers. The proposed study will not only investigate the validity of microbial biomarkers in different types or combinations of samples, but also examine the reliability of these biomarkers from one spot sample vs. collections from two time points in relation to carcinogenesis biomarkers in rectal tissue. The proposed study is unique with a large sample size, multiple sample types, and multiple collections across time points. The results from the proposed study will lay a solid foundation for future large-scale epidemiologic studies of microbiota in association with CRC.

描述（由申请方提供）：尽管结直肠癌的发病率和死亡率均有所降低，部分原因是内窥镜检查的使用迅速增加，但结直肠癌（CRC）仍然是美国第4大最常见的癌症事件和第2大最常见的癌症死亡原因。因此，制定新的预防战略至关重要。人类结肠直肠是数十亿细菌的宿主，这些细菌构成了微生物群。微生物群在结直肠健康的几个功能中至关重要，包括免疫力，营养代谢，生长和能量收集。然而，直到最近，微生物群在健康中的作用的评估一直是有限的，因为大多数细菌是不可培养的。不依赖于培养的下一代16 S核糖体RNA测序允许评估微生物群在健康中的作用。然而，以前对结直肠微生物组的流行病学研究很少，样本量也很小。此外，最近的研究发现，肠道中的氧梯度是体内最陡的，其从粘膜降低到管腔中部的接近缺氧。因此，与粘膜细菌相比，管腔菌群中的微生物更可能是厌氧的。因此，在进行大规模流行病学研究之前，有必要解决两个关键的方法或实际问题。首先，什么样的样品来源最适合于分析人类结直肠微生物组，其次，点样是否足以可靠地代表结直肠微生物组与结直肠癌发生的关系。这项拟议的研究将通过使用100名有结直肠腺瘤病史的参与者（每人4份样本）中2个时间点的库存粪便样本和配对直肠拭子来解决这两个关键问题。在母研究中，在与粪便和直肠拭子样本相同的2个时间点，在正常直肠组织中测量结直肠癌发生生物标志物（细胞凋亡、炎症、增殖和Wnt途径）。在这项拟议的初步研究中，将使用下一代16 S rRNA测序分析样本。我们将比较1）拭子与粪便以及2）拭子和粪便的组合与与免疫组织化学致癌生物标志物相关的单一样本类型。我们还将检查直肠拭子和粪便样本中的微生物生物标志物是否随时间保持稳定;以及进一步2）比较在一个时间点（点采集）采集的粪便和直肠拭子中的微生物生物标志物与两个时间点（间隔3个月）采集的微生物生物标志物与免疫组织化学致癌生物标志物的相关性。拟议的研究不仅将研究不同类型或组合样本中微生物生物标志物的有效性，还将检查来自一个点样本与来自两个时间点的收集的这些生物标志物与直肠组织中致癌生物标志物相关的可靠性。拟定的研究具有独特性，具有较大的样本量、多种样本类型和跨时间点的多个采集。这项研究的结果将为未来与CRC相关的微生物群的大规模流行病学研究奠定坚实的基础。